Drug Profile
Research programme: zolpidem transmucosal - BioDelivery Sciences International
Alternative Names: BEMA™ zolpidem; Transmucosal zolpidemLatest Information Update: 24 Mar 2022
Price :
$50
*
At a glance
- Originator BioDelivery Sciences International
- Class Acetamides; Hypnosedatives; Imidazoles; Pyridines; Sleep disorder therapies; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Insomnia
Most Recent Events
- 22 Mar 2022 BioDelivery Sciences International has been acquired by Collegium Pharmaceutical
- 12 Apr 2007 Zolpidem transmucosal is available for partnering worldwide (http://www.biodeliverysciences.com)
- 15 Mar 2006 Preclinical trials in Insomnia in USA (Transmucosal)